Guardian Pharmacy Services Inc

GRDN remains in an intact uptrend but has pulled back sharply below short-term EMAs into the 38–39 support zone. With price now extreme oversold and no clear reversal yet, execution is deferred. We will stalk for a pullback interaction and acceptance into the 38–39 area before committing to a long.

• ↑Q2 revenue $351.2M (+2% YoY) despite IRA-related price reductions
• ↑Adjusted EBITDA $29.7M (+19% YoY) reflecting operational resilience
• ↓Ongoing IRA pricing adjustments to drive multi-quarter revenue declines